TETRACUMIN
LIVE

Serial Number

87503676

Owner

Tesseract Medical Research, LLC

First Use Date

May 7, 2018

Filing Date

Jun 23, 2017

Add to watchlist:

No watchlists yet
View on USPTO

TETRACUMIN Trademark

Serial Number: 87503676 • Registration: 5602395

TETRACUMIN is a trademark filed by Tesseract Medical Research, LLC on June 23, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Tesseract Medical Research, LLC (58 trademarks)

1370 Trancas Street, Suite 350
Napa, CA 94558

Entity Type: 16

Trademark Details

Filing Date

June 23, 2017

Registration Date

November 6, 2018

First Use Anywhere

May 7, 2018

First Use in Commerce

May 7, 2018

Published for Opposition

April 24, 2018

Goods & Services

Dietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing curcumin; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations for restoring health in individuals with diseases, disorders, and adverse health conditions; dietary supplements for restoring health in individuals with diseases, disorders, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, in the nature of anti-inflammatories for increasing curcumin in the body for the treatment of exaggerated immune response, exaggerated inflammatory response, exaggerated lipid profiles, gastrointestinal disorders, and joint and muscle pain; functional nutrient preparations containing curcumin to mitigate exaggerated immune response, exaggerated inflammatory response, exaggerated lipid profiles, gastrointestinal disorders, and joint and muscle pain; specialty nutraceuticals for the dietary management of diseases, disorders, and adverse health conditions that can be remediated with curcumin, namely, exaggerated immune response, exaggerated inflammatory response, exaggerated lipid profiles, gastrointestinal disorders, and joint and muscle pain

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
May 27, 2025 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
May 27, 2025 8.OK
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
May 12, 2025 EROP
POST REGISTRATION ACTION MAILED - SEC. 8
May 7, 2025 PRA8
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 5, 2025 APRE
TEAS SECTION 8 RECEIVED
Dec 9, 2024 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 6, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 6, 2018 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 3, 2018 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 2, 2018 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 27, 2018 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 22, 2018 AITU
USE AMENDMENT FILED
Aug 29, 2018 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 29, 2018 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 19, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 24, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 24, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 4, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 21, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 21, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 21, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 21, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 3, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 2, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 2, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 28, 2017 GNRN
NON-FINAL ACTION E-MAILED
Sep 28, 2017 GNRT
NON-FINAL ACTION WRITTEN
Sep 28, 2017 CNRT
ASSIGNED TO EXAMINER
Sep 21, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 30, 2017 NWOS
NEW APPLICATION ENTERED
Jun 27, 2017 NWAP